ICON plc (NASDAQ:ICLR), a leading global provider of outsourced drug and device development and commercialization services with an adjusted market capitalization of $13.8 billion, faces a complex ...
ICON plc reported better-than-expected earnings for the second quarter of 2025, with earnings per share (EPS) of $3.26, surpassing the forecast of $3.19. This positive surprise, combined with revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback